A phase I study to evaluate the single-dose and multiple-dose pharmacokinetics and the safety of ursolic acid nanoliposomes (UANL) in healthy volunteers and patients with advanced solid tumors.
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2016
At a glance
- Drugs Ursolic acid (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 14 Jul 2016 New trial record